Home|Journals Follow on Twitter| Subscribe to List

Directory for Medical Articles
 

Open Access

Original Research

Egypt. J. Exp. Biol. (Zoo.). 2009; 5(0): 487-493


HYPOGLYCEMIC EFFECT OF MOMORDICA CHARANTIA (KARELA) ON NORMAL AND ALLOXAN DIABETIC ALBINO MICE

Maliha A. Almarzooq, Eman A. Moussa.

Abstract
The effects of Bitter Melon (Momordica charantia) on the normal and onset of alloxan-induced diabetes in male and female Swiss albino mice were examined. It was observed that the mice given orally juice extract of Bitter melon (10 ml /kg BW for 12 weeks) showed a significant decrease in the blood glucose level and glycosylated hemoglobin A1c of diabetic mice induced by intra-peritoneal injection of alloxan (50 mg/ kg, BW i.p.) and significantly improved the glucose tolerance test. Histological examinations were also done on pancreas. Oral administration of juice extract of Bitter melon (10 ml/ kg BW) three times weekly for 12 weeks showed dramatic regeneration in the pancreatic islets of alloxan diabetic mice. The present results suggest that orally given of fruit juice, M. charantia may have a role in the renewal of β cells in alloxan-diabetic mice or alternately may permit the recovery of partially destroyed β cells. Momordica charantia may effectively normalize blood AST, ALT, creatinine and cholestrol in alloxan induced-diabetic group. These findings revealed that juice extract of bitter melon may have a potential benefit in the treatment of diabetes, play a role in its management and reduces the risk of diabetic complications.

Key words: Karela, Momordica charantia, bitter melon, hyperglycemia, diabetes mellitus.



Share this Article


Advertisement
Progress in Orthopedic Science

SUBMIT YOUR ARTICLE NOW


ScopeMed.com
BiblioMed Home
Follow ScopeMed on Twitter
Author Tools
eJPort Journal Hosting
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License (https://creativecommons.org/licenses/by-nc-sa/4.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.
ScopeMed is a Database Service for Scientific Publications. Copyright ScopeMed Information Services.